Loading...

RBC Lysis Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Red blood cell lysis buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420301 100 mL 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
420302 500 mL 165€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Red Blood Cell (RBC) Lysis Buffer has been designed, formulated, and tested to ensure optimal lysis of RBCs in single cell suspensions with minimal effects on leukocytes. RBC Lysis Buffer is supplied as a 10X solution containing ammonium chloride, potassium carbonate, and EDTA, and should be diluted in deionized water prior to use. Nucleated RBCs are not effectively lysed with ammonium chloride. Test

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
This red blood cell (RBC) lysis buffer is supplied as a 10X solution and should be diluted to 1X in deionized water. 100 ml of 10X concentrate will yield a quantity of 1X solution that is sufficient to lyse 500 samples.
Preparation
The pH of the 1X solution should fall within the range of pH 7.1-7.4. Adjust the pH if necessary. Warm the 1X solution to room temperature prior to use.
Storage & Handling
Store RBC lysis buffer between 2°C and 8°C.
Application Notes

A. Lysis of Mouse Spleen RBCs:
1. Harvest mouse spleen and prepare a single cell suspension.
2. Pellet the cells by centrifugation (350 x g); aspirate the supernatant.
3. Dilute the 10X Red Blood Cell Lysis Buffer to 1X working concentration with deionized water and resuspend the pellet in 5 ml of 1X Lysis Buffer.
4. Incubate on ice for 4-5 minutes with occasional shaking.
5. Stop the reaction by diluting the Lysis Buffer with 20-30 ml of 1X PBS.
6. Spin the cells (350 x g) and discard the supernatant.
7. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer Cat. No. 420201), wash 1X.
8. Count cells, adjust density, and proceed with cell staining procedures.
B. Lysis of Human Peripheral Blood RBCs:
1. Dilute the 10X RBC Lysis Buffer to 1X working concentration with deionized water. Warm the 1X solution to room temperature prior to use.
2. Add 2.0 ml of 1X RBC Lysis Buffer to each tube containing up to 100 µl of whole blood.
3. Gently vortex each tube immediately after adding the lysing solution. Incubate at room temperature, protected from light, for 10-15 minutes.
4. Centrifuge 350 x g for 5 minutes. Aspirate supernatant without disturbing pellet.
5. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer, Cat. No. 420201), wash 1X.
6. Resuspend and proceed with further procedures.

Application References
  1. Adams RA, et al. 2007. J. Exp. Med. 204:571.
  2. Feild-Corbett C, et al. 2009. Stem Cells. PubMed
  3. de Resende MM, et al. 2010. Physiol Genomics. 42:437. PubMed
  4. Roybal JD, et al. 2011. Mol Cancer Res. 9:25. PubMed
  5. Boldin MP, et al. 2011. J Exp Med. PubMed
  6. Kahlenberg JM, et al. 2011. J. Immunol. 187:6143. PubMed
  7. Deiuliis JA, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:399. PubMed
  8. Wu CY, et al. 2012. PLoS One. 7:e42365. PubMed
  9. Hsia BJ, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  10. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  11. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. PubMed
  12. Saraiva AM, 2013. Hum Immunol. 74:207. PubMed
  13. Koon HW, et al. 2013. J Vis exp. 68:4208. PubMed
  14. Ma Dy, et al. 2013. J Virol. 87:3361. PubMed
  15. Han W, 2013. J. Immunol. 190:4786. PubMed
  16. Garcia-Acros I, et al. 2013. J Biol Chem. 288:14046. PubMed
  17. Zhao JL, et al. 2013. Elife. 21:537. PubMed
  18. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. PubMed
  19. Yamasaki S, et al. 2013. Clin Vaccine immunol. 20:1508. PubMed
  20. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  21. Liu X, et al. 2013. Invest Ophthalmol Vis Sci. 54:7386. PubMed
  22. Fullerton AM, et al. 2013. Toxicol Sci. 136:72. PubMed
  23. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  24. Varga T, et al. 2013. J. Immunol. 191:5695. PubMed
  25. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  26. Chang YJ, et al. 2014. Cytotherapy. 16:560. PubMed
  27. Kim MJ, et al. 2014. Mol Pharmacol. 86:284. PubMed
  28. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  29. Szulzewsky F, et al. 2015. PloS One. 10:116644. PubMed
Product Citations
  1. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  2. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  3. Deiuliis J, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:L399. PubMed
  4. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. . PubMed
  5. Barros-Martins J, et al. 2016. J Immunol. 196: 3642 - 3652. PubMed
  6. Zhou B, et al. 2020. Nat Immunol. 1.868055556. PubMed
  7. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  8. Asem M, et al. 2020. Cancer Res. 1156:80. PubMed
  9. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  10. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  11. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  12. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  13. Rathakrishnan A, et al. 2020. Viruses. 12: . PubMed
  14. Wang Y, et al. 2021. Cancer Res. 81:384. PubMed
  15. Wang H, et al. 2022. Nat Biomed Eng. 6:882. PubMed
  16. Yeh PY, et al. 2022. Sens Actuators B Chem. 353: . PubMed
  17. Ammothumkandy A, et al. 2022. Nat Neurosci. 25:493. PubMed
  18. Melendez E, et al. 2022. Development. 149: . PubMed
  19. Argueta LB, et al. 2022. iScience. 25:104223. PubMed
  20. Wang S, et al. 2022. Adv Sci (Weinh). 9:e2201258. PubMed
  21. Meena AS, et al. 2022. Cell Rep. 39:110937. PubMed
  22. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  23. Sugimoto S, et al. 2022. Nat Metab. 4:775. PubMed
  24. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  25. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  26. Xu Q, et al. 2022. Front Med (Lausanne). 9:940554. PubMed
  27. Alexandrou AT, et al. 2022. iScience. 25:105546. PubMed
  28. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  29. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  30. Tratwal J, et al. 2022. Front Endocrinol (Lausanne). 13:1001210. PubMed
  31. Xie Z, et al. 2022. Cell Discov. 8:133. PubMed
  32. Xiang X, et al. 2022. Medicine (Baltimore). 101:e32558. PubMed
  33. Yu Z, et al. 2023. Cancer Res. 83:700. PubMed
  34. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  35. Oh S, et al. 2023. Nat Biotechnol. :. PubMed
  36. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  37. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  38. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  39. Li XF, et al. 2023. J Exp Med. 220: . PubMed
  40. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  41. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  42. Feng J, et al. 2022. Immunity. 55:405. PubMed
  43. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  44. Guennoun R, et al. 2022. Cancers (Basel). 14:. PubMed
  45. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  46. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  47. Wakiyama H, et al. 2022. Cancer Immunol Res. 10:1386. PubMed
  48. Roweth HG, et al. 2022. Sci Adv. 8:eabo5224. PubMed
  49. Zhong J, et al. 2022. J Adv Res. 41:145. PubMed
  50. Yun HJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  51. Daum P, et al. 2023. Front Immunol. 13:991347. PubMed
  52. Rao D, et al. 2023. Eur J Immunol. 53:e2250258. PubMed
  53. Le DT, et al. 2023. iScience. 26:106059. PubMed
  54. Romo-Rodríguez R, et al. 2023. Arch Med Res. 54:197. PubMed
  55. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  56. MacPherson KP, et al. 2023. Front Cell Neurosci. 17:895017. PubMed
  57. Chen Z, et al. 2023. Nat Commun. 14:1839. PubMed
  58. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  59. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  60. Choi YJ, et al. 2023. Nat Commun. 14:2045. PubMed
  61. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  62. Pattnaik A, et al. 2023. Vaccines (Basel). 11:. PubMed
  63. Mulcrone PL, et al. 2023. Sci Rep. 13:8436. PubMed
  64. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  65. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  66. Matsudaira T, et al. 2023. Commun Biol. 6:665. PubMed
  67. Sandovici I, et al. 2022. Dev Cell. 57:63. PubMed
  68. Nguyen, H. P., An, K., et al. 2025. Nat Biotechnol. 43(12),1979-1995. PubMed
  69. Jebbawi, F., Olomski, F., et al. 2025. Allergy. 80(12),3377-3390. PubMed
  70. Xu, L., Paine, A. C., et al. 2025. J Virol. 99(10),e0126125. PubMed
  71. Haykal, T., Yang, R., et al. 2025. Cancer Res. 85(24),4995-5014. PubMed
  72. Li, S., Wang, Y., et al. 2025. Signal Transduct Target Ther. 10(1),323. PubMed
  73. Huang, H., Li, S., et al. 2025. Sci Rep. 15(1),35547. PubMed
  74. Li, Q., de Oliveira Formiga, R., et al. 2025. Nat Metab. 7(12),2510-2530. PubMed
  75. Phoon, Y. P., Wolfarth, A. A., et al. 2025. Sci Rep. 15(1),37950. PubMed
  76. Choi, Y., Shim, M., et al. 2025. Exp Mol Med. 57(11),2487-2504. PubMed
  77. Chen, Y., Liao, Y., et al. 2025. Nat Commun. 16(1),10249. PubMed
  78. Han, C., Yuan, H., et al. 2025. FASEB J. 39(23),e71273. PubMed
  79. Wessel, B. M., Castro, J. N., et al. 2025. Organoids. 4(4),0. PubMed
  80. Qiu, Z., Song, N. J., et al. 2025. J Clin Invest. 0(0),0. PubMed
  81. Lu, W., Jin, T., et al. 2025. Sci Rep. 15(1),44077. PubMed
  82. Izgutdina, A., Rashid, T., et al. 2025. J Immunother Cancer. 13(12),0. PubMed
  83. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  84. Della Verde G, et al. 2022. Life Sci Alliance. 5:. PubMed
  85. Su C, et al. 2021. Front Oncol. 11:719564. PubMed
  86. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  87. Chen Z, et al. 2020. Glia. 68:2148. PubMed
  88. Seow JJW, et al. 2021. Front Med (Lausanne). 8:603374. PubMed
  89. Shin J, et al. 2020. Hum Gene Ther. . PubMed
  90. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  91. Spengler J, et al. 2016. J Infect Dis. 214: S308 - S318. PubMed
  92. Zheng M, et al. 2016. J Immunol. 196: 4122 - 4131. PubMed
  93. St-Pierre S, et al. 2016. PLoS One. 11: 0150230. PubMed
  94. Ensan S, et al. 2015. Nat Immunol. 17: 159-168. PubMed
  95. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  96. Hou J, et al. 2015. J Mol Cell Biol. 7: 338-350. PubMed
  97. Fujii H, et al. 2015. PLoS One. 10: 0133216. PubMed
  98. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  99. Pracht K, et al. 2021. Eur J Immunol. 51:1089. PubMed
  100. Radwanska M, et al. 2020. Methods Mol Biol. 2116:721. PubMed
  101. Rendon CJ, et al. 2022. Front Endocrinol (Lausanne). 13:995499. PubMed
  102. Liu W, et al. 2017. Int J Environ Res Public Health. 10.3390/ijerph14060592. PubMed
  103. Pietrocola F, et al. 2017. Autophagy. 0.935416667. PubMed
  104. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  105. Wang J, et al. 2020. Sci Rep. 10:12785. PubMed
  106. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  107. Magalhães L, et al. 2015. PLoS Negl Trop Dis. 10: 0003816. PubMed
  108. Moraes-Vieira P, et al. 2016. Diabetes. 65: 1317 - 1327. PubMed
  109. Garcia-Fabiani MB, et al. 2020. STAR Protoc. :1. PubMed
  110. Zhang J, et al. 2021. Aging (Albany NY). 13:17880. PubMed
  111. Press AT, et al. 2021. EMBO Mol Med. 13:e14436. PubMed
  112. Sima LE, et al. 2021. J Immunother Cancer. 9:. PubMed
  113. Ma H, et al. 2021. Front Immunol. 12:760095. PubMed
  114. McGill CJ, et al. 2021. STAR Protoc. 2:100948. PubMed
  115. Lutze J, et al. 2022. Methods Mol Biol. 2394:299. PubMed
  116. Hosseini A, et al. 2022. Evid Based Complement Alternat Med. 2022:5639226. PubMed
  117. Bikorimana JP, et al. 2022. Cell Rep Med. 3:100534. PubMed
  118. Zhang L, et al. 2022. JCI Insight. 7:. PubMed
  119. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  120. Wu Y, et al. 2021. Nat Biomed Eng. 5:1336. PubMed
  121. Meng S, et al. 2022. Exp Anim. . PubMed
  122. Kokkinopoulos I, et al. 2021. Sci Rep. 11:15759. PubMed
  123. Johnson CL, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H756. PubMed
  124. Stringhini M, et al. 2021. MAbs. 13:1868066. PubMed
  125. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  126. Elisabeth Schrumpf, Xiaojun Jiang 2017. Physiol Rep. 10.14814/phy2.13117. PubMed
  127. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  128. Brunmeir R, et al. 2016. PLoS Genet. 12:e1006474. PubMed
  129. Pridans C, et al. 2016. J Immunol. 197: 2297 - 2305. PubMed
  130. Mircheff A, et al. 2016. Ocul Surf. 14:460-483. PubMed
  131. Pennington L, et al. 2016. Nat Commun. 7:11610. PubMed
  132. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  133. Boldin M, et al. 2011. J Exp Med. 208:1189. PubMed
  134. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  135. Bravo–San Pedro JM, et al. 2019. Cell Metab. 30:754. PubMed
  136. Clark EL, et al. 2017. PLoS Genet. 13:e1006997. PubMed
  137. Cantor JR, et al. 2017. Cell. 169:258. PubMed
  138. Ji WJ, et al. 2017. Cytometry B Clin Cytom. 92:371. PubMed
  139. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  140. Sakamoto S, et al. 2020. OncoImmunology. 8(12):e1671760.. PubMed
  141. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  142. Hamour S, et al. 2015. PLoS One. 10: 0136238. PubMed
  143. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  144. Luo B, et al. 2016. J Neurosci. 36: 9590 - 9603. PubMed
  145. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  146. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  147. Zhai Z, et al. 2021. Medicine (Baltimore). 100:e26214. PubMed
  148. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  149. Jones N, et al. 2021. Nat Commun. 12:1209. PubMed
  150. Wang D, et al. 2021. Signal Transduct Target Ther. 6:376. PubMed
  151. Machado H, et al. 2021. PLoS Pathog. 17:e1009933. PubMed
  152. Yan X, et al. 2022. Int J Biol Sci. 18:585. PubMed
  153. Singh SS, et al. 2021. Eur J Med Chem. 216:113312. PubMed
  154. Pokhrel RH, et al. 2022. Int J Mol Sci. 23:. PubMed
  155. Neufeld L, et al. 2021. Sci Adv. 7:. PubMed
  156. Friedman G, et al. 2020. Nat Cancer. 1:692. PubMed
  157. Kumar A, et al. 2021. Part Fibre Toxicol. 18:43. PubMed
  158. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  159. Scherer SD, et al. 2021. Breast Cancer Res. 23:100. PubMed
  160. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  161. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  162. Orr AN, et al. 2021. Int J Mol Sci. 22:. PubMed
  163. Facchini M, et al. 2014. J Vis Exp. 85: 51019. PubMed
  164. Ilievski V, et al. 2015. PLoS One. 10: 0136502. PubMed
  165. Saraiva A, et al. 2013. Hum Immunol. 74:207. PubMed
  166. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  167. Jiang J, et al. 2018. Cancer Med. 3.504861111. PubMed
  168. Chen Z, et al. 2017. Cancer Res. 77:2266. PubMed
  169. Kim M, et al. 2017. Int J Mol Sci. 10.3390/ijms18061275. PubMed
  170. Mo L, et al. 2022. Front Oncol. 12:871489. PubMed
  171. Huang L, et al. 2021. J Cell Physiol. 236:7308. PubMed
  172. Whytock KL, et al. 2022. iScience. 25:104772. PubMed
  173. Wang K, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.016. PubMed
  174. Appelbe O, et al. 2017. J Control Release.. 10.1016/j.jconrel.2017.09.043. PubMed
  175. Tang J, et al. 2017. Proc Natl Acad Sci U S A. 114:E7441. PubMed
  176. Liccardi G, et al. 2019. Mol Cell. 73:413. PubMed
  177. Patil R, et al. 2019. J Biomed Opt. 24:1. PubMed
  178. Ongaro T, et al. 2020. Oncotarget. 3.026388889. PubMed
  179. Kahlenberg J, et al. 2011. J Immunol. 187:6143. PubMed
  180. Han W, et al. 2013. J Immunol. 190:4786. PubMed
  181. Yamasaki S, et al. 2013. Clin Vaccine Immunol. 20:1508. PubMed
  182. Fukui R, et al. 2016. J Immunol. 196: 416 - 427. PubMed
  183. Rodriguez-Garcia M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.72. PubMed
  184. Kildisiute G, et al. 2021. Sci Adv. 7: . PubMed
  185. Schiferle EB, et al. 2021. Sci Adv. 7: . PubMed
  186. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  187. Bigenwald C, et al. 2021. Nat Med. 27:851. PubMed
  188. Gingrich AA, et al. 2021. Front Immunol. 12:670309. PubMed
  189. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  190. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  191. Vivanco Gonzalez N, et al. 2022. STAR Protoc. 3:101280. PubMed
  192. Qin L, et al. 2022. Nat Commun. 13:6051. PubMed
  193. Escudero-Lara A, et al. 2022. Front Behav Neurosci. 16:946975. PubMed
  194. Evans AK, et al. 2020. Neurobiol Dis. 146:105089. PubMed
  195. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  196. Choi JW, et al. 2020. PLoS One. 15:e0235518. PubMed
  197. Alban TJ, et al. 2020. Front Immunol. 1.285416667. PubMed
  198. Jiang S, et al. 2017. Toxicology Lett. 10.1016/j.toxlet.2017.03.015. PubMed
  199. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  200. Martínez-Muriana A, et al. 2020. Stem Cell Res Ther. 11:53. PubMed
  201. Pennig J, et al. 2019. Sci Rep. 9:17937. PubMed
  202. Wang B, et al. 2017. Stem Cell Res Ther.. 10.1186/s13287-017-0744-6. PubMed
  203. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  204. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  205. Elphinstone R, et al. 2017. Infect Immun. 10.1128/IAI.00371-17. PubMed
  206. Kernfeld EM, et al. 2018. Immunity. 48:1258. PubMed
  207. Nwani NG, et al. 2019. Cancers (Basel). 0.806944444. PubMed
  208. Ramalingam P, et al. 2020. Nat Commun. 11:666. PubMed
  209. Garcia-Arcos I, et al. 2013. J Biol Chem. 288:14046. PubMed
  210. Sci T 2013. Toxicol Sci. 136:72. PubMed
  211. Metz H, et al. 2016. Proc Natl Acad Sci U S A. 113: 8795 - 8800. PubMed
  212. Cheng Q, et al. 2020. Nat Nanotechnol. 0.842361111. PubMed
  213. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  214. Alghamri MS, et al. 2020. Methods Enzymol. 632:215. PubMed
  215. Yu Z, et al. 2021. Front Oncol. 11:659251. PubMed
  216. Deng J, et al. 2021. Nat Cancer. 2:503. PubMed
  217. Beaudoin-Bussières G, et al. 2022. Cell Rep. 38:110368. PubMed
  218. Hu H, et al. 2021. Cancer Immunol Res. 9:1298. PubMed
  219. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  220. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  221. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  222. Ullah I, et al. 2021. Immunity. 54:2143. PubMed
  223. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  224. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  225. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  226. Meng YM, et al. 2021. Nat Commun. 12:6011. PubMed
  227. Zhu QY, et al. 2021. Nat Commun. 12:6624. PubMed
  228. Patel M, et al. 2021. Cancer Res. 81:3985. PubMed
  229. Shi X, et al. 2021. Nat Commun. 12:2547. PubMed
  230. Ramaswamy G, et al. 2017. Sci Rep. 10.1038/srep45140. PubMed
  231. Lizotte P, et al. 2016. Sci Rep. 6:31745. PubMed
  232. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  233. Rosenbluth JM, et al. 2020. Nat Commun. 11:1711. PubMed
  234. Tavakol DN, et al. 2021. Curr Protoc. 1:e275. PubMed
  235. Wen J, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0489-9. PubMed
  236. Ahmad S,et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. . 10.1016/j.pnpbp.2017.10.001. PubMed
  237. Hang J, et al. 2019. Cancer Med. 1.254166667. PubMed
  238. Tan X, et al. 2019. Sci Rep. 2.7125. PubMed
  239. Lienemann PS, et al. 2020. Adv Sci (Weinh). 7:1903395. PubMed
  240. Zhao J, et al. 2013. Elife. 21:537. PubMed
  241. Weber G, et al. 2015. Surgery. 158: 248-254. PubMed
  242. Jiang H, et al. 2016. Nat Med. 10.1038/nm.4123. PubMed
  243. Elgueta R, et al. 2016. J Immunol. 197: 3970 - 3981. PubMed
  244. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  245. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  246. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  247. Pace J, et al. 2022. J Biomed Opt. 27:. PubMed
  248. Pedicona F, et al. 2022. Sci Signal. 15:eabl7989. PubMed
  249. Fidalgo MF, et al. 2022. Life Sci Alliance. 5:. PubMed
  250. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  251. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  252. Castoldi F, et al. 2020. Cell Death Discov. 0.339583333. PubMed
  253. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  254. Morris C, et al. 2017. MBio. 10.1128/mBio.00036-17. PubMed
  255. Theurl I, et al. 2016. Nat Med. 10.1038/nm.4146. PubMed
  256. Schweppe RE, et al. 2019. Mol Cancer Res. 17:1036. PubMed
  257. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  258. Yang A, et al. 2018. Cancer Discov. 0.525. PubMed
  259. Rentsendorj A, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.08.019. PubMed
  260. Yan Q, et al. 2022. Clin Transl Med. 12:e1084. PubMed
  261. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  262. Dyck S, et al. 2018. J Neuroinflammation. 0.6875. PubMed
  263. Yang YS, et al. 2020. Mol Ther Methods Clin Dev. 17:922. PubMed
  264. Gangwar RS, et al. 2020. Sci Rep. 10:14348. PubMed
  265. Varga T, et al. 2013. J Immunol. 191:5695. PubMed
  266. Samuelson D, et al. 2016. J Immunol. 196: 2655 - 2665. PubMed
  267. Tsao P, et al. 2016. Proc Natl Acad Sci U S A. 113: 8242 - 8247. PubMed
  268. Soncini M, et al. 2016. Proc Natl Acad Sci U S A. 113: E6219 - E6227. PubMed
  269. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  270. Nowyhed H, et al. 2017. Sci Rep. 7:40273. PubMed
  271. De Domenico E, et al. 2020. STAR Protoc. 1:100233. PubMed
  272. Wang Z, et al. 2020. Cell Rep. 33:108472. PubMed
  273. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  274. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  275. Ito T, et al. 2021. Nat Commun. 12:2232. PubMed
  276. Hollerbach A, et al. 2021. J Thromb Haemost. . PubMed
  277. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  278. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  279. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  280. Majumdar D, et al. 2021. Curr Protoc. 1:e216. PubMed
  281. Michelotti TC, et al. 2022. Front Cell Dev Biol. 10:1025240. PubMed
  282. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  283. Yamazaki T, et al. 2021. Oncoimmunology. 10:1962592. PubMed
  284. Zhang J, et al. 2020. Pain. 161:1381. PubMed
  285. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  286. Canali S, et al. 2017. Blood. 129(4):405-414. PubMed
  287. Shen X, et al. 2016. Sci Rep. 6:38778. PubMed
  288. Sauter K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G533 - G547. PubMed
  289. Song C, et al. 2015. Blood. 126: 1813 - 1822. PubMed
  290. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  291. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  292. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  293. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  294. Bowers J, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01221. PubMed
  295. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  296. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  297. Xiang Y, et al. 2022. Skelet Muscle. 12:19. PubMed
  298. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  299. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  300. Bichsel C, et al. 2017. Sci Rep. 10.1038/s41598-017-09928-1. PubMed
  301. James M, et al. 2017. J Nucl Med. . 10.2967/jnumed.117.189597. PubMed
  302. Annibaldi A, et al. 2018. Mol Cell. 69:566. PubMed
  303. Hill SJ, et al. 2018. Cancer Discov. 1.308333333. PubMed
  304. Ma D, et al. 2013. J Virol. 87:3361. PubMed
  305. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  306. Kim M, et al. 2014. Mol Pharmacol. 86:284. PubMed
  307. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  308. Pankova D, et al. 2016. Mol Cancer Res. 14: 287 - 295. PubMed
  309. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  310. Tulasi DY, et al. 2021. Cell Mol Gastroenterol Hepatol. 11:1437. PubMed
  311. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  312. Xue X, et al. 2021. Cent Eur J Immunol. 46:191. PubMed
  313. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  314. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  315. McClellan BL, et al. 2022. STAR Protoc. 3:101357. PubMed
  316. Governa V, et al. 2022. Proc Natl Acad Sci U S A. 119. PubMed
  317. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  318. Mai CL, et al. 2021. Theranostics. 11:1059. PubMed
  319. Chen P, et al. 2021. Clin Transl Med. 11:e462. PubMed
  320. Peng X, et al. 2021. Stem Cell Res Ther. 198:12. PubMed
  321. Linder A, et al. 2020. EMBO J. 39:e105071. PubMed
  322. Muñoz-Ruiz M, et al. 2016. Nat Immunol. 10.1038/ni.3424. PubMed
  323. Chang Y, et al. 2014. Cytotherapy. 16:560. PubMed
  324. Hsia B, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  325. Resende M, et al. 2010. Physiol Genomics. 42:437. PubMed
  326. McLaughlin S, et al. 2019. Nat Commun. 3.795833333. PubMed
  327. Koury J, et al. 2019. PLoS One. 14:e0218670. PubMed
  328. Zhang Z, et al. 2017. Journal of Translational Medicine. 10.1186/s12967-017-1196-6. PubMed
  329. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  330. Soileau AM, et al. 2022. Vet Sci. 9:. PubMed
  331. Mochizuki M,et al. 2017. J Am Heart Assoc. . 10.1161/JAHA.117.005920. PubMed
  332. Roh–Johnson M, et al. 2017. Dev Cell. 43:549. PubMed
  333. Müller C, et al. 2018. Elife. 7:e34985. PubMed
  334. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. . PubMed
  335. Liu Y, et al. 2015. Sci Rep. 5: 15134. PubMed
  336. Hodson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 2039-2046. PubMed
  337. Munson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 8272 - 8277. PubMed
  338. Ubellacker J, et al. 2017. Breast Cancer Res. 10.1186/s13058-017-0815-8. PubMed
  339. DU T, et al. 2020. Front Immunol. 1.571527778. PubMed
  340. Trial J, et al. 2020. Geroscience. . PubMed
  341. Cordo' V, et al. 2022. Nat Commun. 13:1048. PubMed
  342. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  343. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  344. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  345. Nagree MS, et al. 2022. EMBO Mol Med. 14:e14297. PubMed
  346. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  347. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  348. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  349. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  350. Wu R, et al. 2020. J Immunother Cancer. 8:00. PubMed
  351. Yu H, et al. 2016. Sci Rep. 6:35190. PubMed
  352. Now H, Yoo J 2016. Cell Mol Immunol. 10.1038/cmi.2016.32. PubMed
  353. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  354. YC S, SJ L 2015. Sci Rep. 5: 12578. PubMed
  355. Szulzewsky F, et al. 2015. PLoS One. 10:116644. PubMed
  356. Wu C, et al. 2012. PLoS One. 7:e42363. PubMed
  357. Denning W, et al. 2011. PLoS One. 6:e16897. PubMed
  358. Weaver J, et al. 2017. Part Fibre Toxicol. 10.1186/s12989-017-0206-4. PubMed
  359. Samuelson D, et al. 2017. PLoS Pathogens. 13(6):e1006426. PubMed
  360. Wong C, et al. 2017. J Immunol. 10.4049/jimmunol.1700397. PubMed
  361. Visweshwaran SP, et al. 2022. Front Cell Dev Biol. 10:1008898. PubMed
  362. Li Q, et al. 2022. Signal Transduct Target Ther. 7:222. PubMed
  363. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  364. Roybal J, et al. 2011. Mol Cancer Res. 9:25. PubMed
  365. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  366. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  367. Park HJ, et al. 2021. Int J Mol Sci. 22:. PubMed
  368. Cebrian-Silla A, et al. 2021. Elife. 10:. PubMed
  369. Yeini E, et al. 2021. Nat Commun. 12:1912. PubMed
  370. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  371. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  372. Kucykowicz S, et al. 2022. STAR Protoc. 3:101356. PubMed
  373. Kim TW, et al. 2022. Mol Ther Oncolytics. 26:1. PubMed
  374. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  375. Shaashua L, et al. 2022. Nat Commun. 13:6513. PubMed
  376. Wahane S, et al. 2021. Sci Adv. 7:. PubMed
  377. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  378. Huang N, et al. 2021. Nat Med. 27:892. PubMed
  379. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  380. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  381. Erady C, et al. 2021. NPJ Genom Med. 6:04. PubMed
  382. de Silva S, et al. 2020. Cancer Immunol Res. 0.493055556. PubMed
  383. Wan C, et al. 2021. Cancer Res. 81:158. PubMed
  384. Wang X, et al. 2016. J Virol. 90: 10247 - 10258. PubMed
  385. Mohammed R, et al. 2016. Cell Rep. 14:760-771. PubMed
  386. Durward-Diioia M, et al. 2015. Infect Immun . 83: 4759 - 4771. PubMed
  387. Birnie K, et al. 2015. Mol Cancer Res. 13: 1106 - 1118. PubMed
  388. Liu X, et al. 2013. Invest Ophthalmol Vis Sci . 54:7386. PubMed
  389. Field-Corbett C, et al. 2009. Stem Cells. 27:662. PubMed
  390. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  391. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  392. Tomas C, et al. 2019. Sci Rep. 9:11464. PubMed
  393. Kim JK, et al. 2019. Bioengineering (Basel). 6:24. PubMed
  394. Alizadeh A, et al. 2018. J Neuroinflammation. 15:53. PubMed
  395. Guo P, et al. 2017. J Clin Invest. 127:4242. PubMed
  396. Tsai SC, et al. 2017. Biomicrofluidics. 11:034122. PubMed
  397. Roy IM, et al. 2021. Bio Protoc. 11:e4130. PubMed
  398. Alam A, et al. 2022. STAR Protoc. 3:101563. PubMed
  399. Xiang Y, et al. 2022. Exp Mol Med. 54:1011. PubMed
  400. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  401. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed

Antigen Details

Cell Type
Tregs
Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 06/10/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account